Because IDH-mutant infiltrating astrocytoma also commonly harbor TP53 and ATRX mutations, these genes can act as additional markers for distinguishing between IDH-mutated astrocytomas and oligodendrogliomas. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).